Henry Schein, Inc.
Financials
Valuation Metrics
Henry Schein, Inc.'s Market Cap is $9.85B. At end of 2025 it was $8.87B. Ranked #957 of 3,112 in US market (top 31%), #308 of 1,445 on NASDAQ (top 21%), #64 of 206 in Health Care Equipment & Services (top 31%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $9.85B | US#957/3,112 Sec#64/206 |
| Revenue | $13.38B | US#466/3,112 Sec#30/206 |
| Net Income | $395M | US#937/3,112 Sec#50/206 |
| Total Assets | $11.30B | US#914/3,112 Sec#44/206 |
| Net Assets | $3.27B | US#936/3,112 Sec#48/206 |
| Employees | 25,000 | US#293/3,112 Sec#28/206 |
| Value | ||
| P/E | 24.94x | US#1,283/3,112 Sec#39/206 |
| P/B | 3.02x | US#1,684/3,112 Sec#98/206 |
| P/S | 0.74x | US#453/3,112 Sec#36/206 |
| EV/EBITDA | 13.43x | US#1,267/3,112 Sec#44/206 |
| FCF Yield | 4.38% | US#1,431/3,112 Sec#78/206 |
| Profitability | ||
| ROE | 12.09% | US#1,116/3,112 Sec#52/206 |
| ROA | 3.49% | US#1,287/3,112 Sec#81/206 |
| Op. Margin | 5.60% | US#2,009/3,112 Sec#105/206 |
| Revenue Growth | 6.31% | US#1,617/3,112 Sec#119/206 |
| Earnings Growth | -2.73% | US#1,445/3,112 Sec#71/206 |
| Financial Health | ||
| Debt Ratio | 198.47% | US#1,778/3,112 Sec#155/206 |
| Total Debt | $3.75B | US#812/3,112 Sec#37/206 |
| FCF | $431M | US#928/3,112 Sec#54/206 |
| Cash | $138M | US#1,995/3,112 Sec#126/206 |
| Current Ratio | 1.36x | US#1,814/3,112 Sec#162/206 |
| Net Debt/EBITDA | 3.60x | US#1,796/3,112 Sec#112/206 |
| Performance | ||
| 1Y Return | 27.20% | US#1,369/3,112 Sec#89/206 |
| 1M Return | 0.05% | US#1,640/3,112 Sec#108/206 |
| From 52W High | -3.21% | US#364/3,112 Sec#23/206 |
| 1Y MDD | -17.23% | US#469/3,112 Sec#8/206 |
| Trading | ||
| Volume | 1,696,125 shares | US#1,025/3,112 Sec#61/206 |
| Trading Value | $147M | US#669/3,112 Sec#53/206 |
| Per Share | ||
| EPS | $3.39 | US#899/3,112 Sec#55/206 |
| BPS | $27.65 | US#927/3,112 Sec#55/206 |
Company Info
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.